|
|
 |
SENSEX
|
 |
-265.80
|
-1.10%
|
24008.00
|
|
|
NIFTY
|
 |
-880.34
|
-1.10%
|
79454.47
|
|
|
Nasdaq
|
 |
189.98
|
1.07%
|
17928.14
|
|
|
Nikkei 225
|
 |
148.97
|
0.41%
|
36928.63
|
|
|
FTSE 100
|
 |
-27.69
|
-0.32%
|
8531.61
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Cipla |
BSE Code |
500087
|
ISIN Demat |
INE059A01026
|
Book Value (Rs) |
378.53
|
|
NSE Code |
CIPLA
|
Dividend Yield % |
0.88
|
Market Cap (Rs) |
1194096.33
|
|
TTM PE(x) |
25.66
|
TTM EPS(Rs) |
57.63
|
Face Value(Rs.) |
2
|
|
|
|
|
|
|
Incorporation Year
|
17-08 1935
|
Registered Office
|
Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel, Mumbai, Maharashtra-400013 .
|
ISINNO
|
INE059A01026
|
Phone
|
022-24826000
|
E-mail
|
contactus@cipla.com |
URL
|
www.cipla.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Y K Hamied
|
Managing Director
|
Umang Vohra
|
Company Secretary
|
Rajendra Chopra
|
Listing
|
BSE,NSE,Luxembourg
|
|
|
|
|
|
|
|
|
|
|
|